Acta Chir Orthop Traumatol Cech. 2020; 87(2):129-133 | DOI: 10.55095/achot2020/021
Heparin-Induced Thrombocytopenia after Total Knee ReplacementCase report
- 1 Klinika ortopedie a traumatologie pohybového ústrojí Lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Plzeň
- 2 NTIS (Nové technologie pro informační společnost), Západočeská univerzita v Plzni
- 3 Ústav klinické biochemie a hematologie Lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Plzeň
Heparin-induced thrombocytopenia is a rare complication of treatment with both unfractionated heparin (UFH) and low molecular weight heparin (LMWH). Antibodies against the complex heparin-platelet factor 4 are the main cause of pathogenesis, resulting in the activation of thrombocytes, coagulation, endothelium, monocytes, neutrophils and subsequent highly prothrombotic state. The prothrombotic state can result not only in venous but also in arterial thrombosis at different locations (which is manifested apart from venous thromboembolic disease also by acute limb ischemia, acute myocardial infarction, ischemic stroke, skin necrotizing lesion exanthema). If HIT is not adequately treated, it may be fatal in up to 10% of patients. For early diagnosis, a combination of 4T scores and diagnostic lab tests for HIT is required. Immediate discontinuation of heparin therapy (UFH, LMWH) and switching to non-heparin anticoagulants (fondaparinux, bivalirudin, argatroban or in some situations DOACs) are essential in HIT treatment. The case report describes the patient after primary knee replacement, complicated by the development of HIT with no evidence of venous thromboembolic disease. Preoperatively, the patient was administrated nadroparin due to paroxysmal atrial fibrillation, after the development of HIT, anticoagulation was modified to fondaparinux and subsequently to warfarin after the platelet count normalization.
Keywords: unfractioned heparin, low molecular weight heparin, thrombocytopenia, total knee replacement
Published: April 1, 2020 Show citation
References
- Cuker A. Management of the multiple phases of heparin-induced thrombocytopenia. Thromb Haemost. 2016;116:835-842.
Go to original source...
Go to PubMed...
- Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018;22:3360-3392.
Go to original source...
Go to PubMed...
- Delgado-García G, Monreal-Robles R. Acute apixaban treatment of heparin-induced thrombocytopenia. J Thromb Thrombolysis. 2017;43:289-290. Epub 2016.
Go to original source...
Go to PubMed...
- Dong K, Song Y, Li X, Ding J, Gao Z, Lu D, Zhu Y. Pentasaccharides for the prevention of venous thromboembolism. Cochrane Database Syst Rev. 2016;10:CD005134.
Go to original source...
Go to PubMed...
- Gallo T, Curry SC, Padilla-Jones A, Heise CW, Ramos KS, Woosley RL, Raschke RA. A Computerized scoring system to improve assessment of heparin-inducedthrombocytopenia risk. J Thromb Haemost. 2019;17:383-388. Epub 2018
Go to original source...
Go to PubMed...
- Chow VW, Abnousi F, Huddleston JI, Lin LH. Heparin-induced thrombocytopenia after total knee arthroplasty, with subsequent adrenal hemorrhage. J Arthroplasty. 2012;27:e15-e18.
Go to original source...
Go to PubMed...
- Ivascu NS, Fitzgerald M, Ghadimi K, Patel P, Evans AS, Goeddel LA, Shaefi S, Klick J, Johnson A, Raiten J, Horak J, Gutsche J. Heparin-induced thrombocytopenia: a review for cardiac anesthesiologists and intensivists. J Cardiothorac Vasc Anesth. 2019;33:511-520. Epub 2018.
Go to original source...
Go to PubMed...
- McMahon CM, Tanhehco YC, Cuker A. Inappropriate documentation of heparin allergy in the medical record because of misdiagnosis of heparin-induced thrombocytopenia: frequency and consequences. J Thromb Haemost. 2017;15:370-374. Epub 2016.
Go to original source...
Go to PubMed...
- Minet V, Dogné JM, Mullier F. Functional assays in the diagnosis of heparin-induced thrombocytopenia: a review. Molecules. 2017;22. pii:E617.
Go to original source...
Go to PubMed...
- Ong SY, Chin YA, Than H, Tan CW, Yap ES, Wong WH, Ng HJ. Rivaroxaban for heparin-induced thrombocytopenia: adding to the evidence. Ann Hematol. 2017;96:525-527.
Go to original source...
Go to PubMed...
- Pishko AM, Fardin S, Lefler DS, Paydary K, Vega R, Arepally GM, Crowther M, Rice L, Cines DB, Cuker A. Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia. Blood Adv. 2018;2:3155-3162.
Go to original source...
Go to PubMed...
- Plath J, Schulze R, Barz D, Krammer B, Steiner M, Anders O, Mach J. Necrotizing skin lesions induced by low-molecular-weight heparin after total knee arthroplasty. Arch Orthop Trauma Surg. 1997;116:443-445.
Go to original source...
Go to PubMed...